I would expect directors to buy at this rock bottom prices to instill some confidence and at least bloody release that. Lack of that is even more concerning.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025